Skip to main content
Fig. 3 | Radiation Oncology

Fig. 3

From: Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers

Fig. 3

Cumulative risks of TLN of patients with any HNC, NPC, and non-NPC HNC receiving PBT or VMAT. Kaplan–Meier analysis comparing the cumulative risks of TLN between PBT and VMAT in patients with any HNC (A), patients with NPC (B), and patients with non-NPC HNC (C). The risks of TLN were comparable between PBT and VMAT in all the subgroups. HNC Head and neck cancer; NPC Nasopharyngeal carcinoma; PBT Proton beam therapy; TLN Temporal lobe necrosis; VMAT Volumetric modulated arc therapy

Back to article page